Edward Susman

ORLANDO, Fla -- May 19, 2026 -- Treatment with mepolizumab appears to deliver limited benefits to patients diagnosed with eosinophilic chronic obstructive pulmonary disease (COPD), according to a meta-analysis of 4 randomised controlled trials comprising over 1,900 patients.

VIRTUAL -- May 5, 2026 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy for patients diagnosed with both obesity and liver cirrhosis reduced overall mortality risk when compared with patients who had a history of bariatric surgery, although there are hints that GLP-1 treatment in this population may increase the risk of hepatocellular carcinoma (HCC), according to research presented at Digestive Disease Week (DDW) 2026.

VIRTUAL -- May 5, 2026 -- Patients diagnosed with chronic pancreatitis who were at risk of pancreatic ductal carcinoma had a significantly lower chance of developing the cancer if they were on statins, according to research presented at Digestive Disease Week (DDW) 2026.